OPEN YOUR EYES TO ISOFORM DIVERSITY
With PacBio long-read sequencing, you’ll see the complete picture of isoform diversity in your cancer samples. Our technology can help reveal gene fusions, splice variants, and novel isoforms to expose hidden biology and discover novel biomarkers for early detection, cancer stratification, and drug resistance.
Tell us how the Iso-Seq method will drive new discoveries in your cancer research for a chance to win SMRTbell library construction (4 samples), PacBio sequencing (up to 8 Sequel SMRT Cells), and bioinformatics analysis.
Submit your 250-word proposal by May 15, 2017.
One winner will be selected from all qualified applications by a panel of scientists.
Get inspired and learn how scientists are using the Iso-Seq method to reveal new biology
- Using the PacBio Iso-Seq Method to Search for Novel Colorectal Cancer Biomarkers
- Characterization of Fusion Genes and the Significantly Expressed Fusion Isoforms in Breast Cancer by Hybrid Sequencing
Read the official rules.
Learn about our SMRT Grant Partner
Thanks to our partner for making the 2017 SMRT Grant Program possible!
GENEWIZ is a global leader in genomics services that enable research scientists within pharmaceutical, biotechnology, agriculture, environmental and clean energy, academic, and government institutions to advance their discoveries. Customers rely on our unique and proprietary genomics technologies and services, backed by our specialized experts in next generation and Sanger sequencing, gene synthesis, molecular biology, bioinformatics, and GLP regulatory-compliant services.
Need some inspiration? Learn more about the Iso-Seq application.